Francisco Novoa-Vasques

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Impact of empagliflozin on serum calcium and phosphate in heart failure.

Impact of empagliflozin on serum calcium and phosphate in heart failure.

Journal: Journal of cardiac failure

Published: May 20, 2026

Oral iron for the management of iron-deficient anemia in SGLT2i-treated heart failure patients: a prospective study.

Oral iron for the management of iron-deficient anemia in SGLT2i-treated heart failure patients: a prospective study.

Journal: Journal of cardiac failure

Published: May 05, 2026

Cystatin-C Versus Creatinine and Kidney Function in Heart Failure With Preserved Ejection Fraction: A SOGALDI-PEF Analysis.

Cystatin-C Versus Creatinine and Kidney Function in Heart Failure With Preserved Ejection Fraction: A SOGALDI-PEF Analysis.

Journal: The American journal of cardiology

Published: May 04, 2026

Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction.

Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction.

Journal: Journal of the American Heart Association

Published: March 13, 2026

PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2.

PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2.

Journal: European journal of heart failure

Published: March 05, 2026

Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials.

Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials.

Journal: European journal of internal medicine

Published: March 05, 2026

Heart Failure "Nudges" for Treatment Optimization in the Emergency Department: The Nudge HF study.

Heart Failure "Nudges" for Treatment Optimization in the Emergency Department: The Nudge HF study.

Journal: European journal of heart failure

Published: February 23, 2026

Myocardial Oedema in Heart Failure with Preserved Ejection Fraction: Preliminary Findings from the NETDiamond Cohort.

Myocardial Oedema in Heart Failure with Preserved Ejection Fraction: Preliminary Findings from the NETDiamond Cohort.

Journal: European journal of heart failure

Published: February 18, 2026

Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis.

Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis.

Journal: European journal of heart failure

Published: January 29, 2026

Impact of dapagliflozin, spironolactone and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF.

Impact of dapagliflozin, spironolactone and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF.

Journal: European journal of heart failure

Published: January 26, 2026

Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF.

Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF.

Journal: JACC. Heart failure

Published: January 05, 2026

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

Journal: Diabetes, obesity & metabolism

Published: December 23, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026